[1] |
World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organization, 2017.
|
[2] |
World Health Organization. Roadmap for childhood tuberculosis: toward zero deaths. Geneva: World Health Organization, 2013.
|
[3] |
World Health Organization. The end TB strateny: global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization, 2015.
|
[4] |
Graham SM, Donald PR . Death and disability:the outcomes of tuberculous meningitis. Lancet Infect Dis, 2014,14(10):902-904.
doi: 10.1016/S1473-3099(14)70872-2
URL
pmid: 25108336
|
[5] |
Graham SM, Sismanidis C, Menzies HJ , et al. Importance of tuberculosis control to address child survival. Lancet, 2014,383(9928):1605-1607.
doi: 10.1016/S0140-6736(14)60420-7
URL
pmid: 5503686
|
[6] |
World Health Organization. Global tuberculosis report 2012. Geneva: World Health Organization, 2012.
|
[7] |
Jenkins HE, Tolman AW, Yuen CM , et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet, 2014,383(9928):1572-1579.
doi: 10.1016/S0140-6736(14)60195-1
URL
|
[8] |
World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization, 2015.
|
[9] |
全国结核病流行病学抽样调查技术指导组. 第四次全国结核病流行病学抽样调查报告. 中华结核和呼吸杂志, 2002,25(1):3-7.
doi: 10.3760/j:issn:1001-0939.2002.01.002
URL
|
[10] |
李亮, 端木宏谨 . 1979—2000年四次全国儿童结核病流行病学抽样调查分析. 中华医学杂志, 2004,84(20):1678-1680.
|
[11] |
刘二勇, 马艳, 李涛 , 等. 全国14岁以下儿童肺结核疫情特征分析. 中国防痨杂志, 2014,36(12):1015-1020.
doi: 10.3969/j.issn.1000-6621.2014.12.004
URL
|
[12] |
World Bank . World development indicators 2013: population dynamics. Washington: World Bank, 2013: 8.
|
[13] |
Jiao WW, Liu ZG, Han R , et al. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Tuberculosis (Edinb), 2015,95(3):315-320.
doi: 10.1016/j.tube.2015.02.041
URL
pmid: 25814302
|
[14] |
Yin QQ, Jiao WW, Han R , et al. Rapid diagnosis of childhood pulmonary tuberculosis by Xpert MTB/RIF assay using bronchoalveolar lavage fluid. Biomed Res Int, 2014: 310194.
|
[15] |
Dodd PJ, Gardiner E, Coghlan R , et al. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical mo-delling study. Lancet Glob Health, 2014,2(8):e453-459.
doi: 10.1016/S2214-109X(14)70245-1
URL
pmid: 25103518
|
[16] |
World Health Organization. Global tuberculosis control: WHO report 2016. Geneva: World Health Organization, 2016.
doi: 10.1111/j.1753-6405.2012.00928.x
URL
|
[17] |
World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization, 2015.
doi: 10.1136/thoraxjnl-2012-201587
URL
pmid: 25973515
|
[18] |
Frieden T, Sterling T, Munsiff S , et al. Tuberculosis. Lancet, 2003,362:887-899.
doi: 10.1016/S0140-6736(03)14333-4
URL
|
[19] |
Chen R, Wang J, Zhang Y , et al. Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity. Arch Toxicol, 2015,89(6):883-897.
doi: 10.1007/s00204-015-1473-1
URL
|
[20] |
Luzzati R, Migliori GB, Zignol M , et al. Children under 5 years are at risk for tuberculosis after an occasional contact with highly contagious patients: an out-patient outbreak from a smear positive health care worker. Eur Respir J, 2017, 50(5). pii: 1701414.
doi: 10.1183/13993003.01414-2017
URL
|
[21] |
World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. Geneva: World Health Organization, 2012.
|
[22] |
Carvalho I, Goletti D, Manga S , et al. Managing latent tuberculosis infection and tuberculosis in children. Pulmonology, 2018,24(2):106-114.
doi: 10.1016/j.rppnen.2017.10.007
URL
pmid: 29502937
|
[23] |
World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization, 2014.
URL
pmid: 17131777
|
[24] |
World Health Organization. The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance. Geneva: World Health Organization, 2016.
|
[25] |
World Health Organization. The use of molecular line probe assays for the detection of resistance to isoniazid and rifam-picin. Geneva: World Health Organization, 2016.
|
[26] |
World Health Organization. The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs: policy guidance. Geneva: World Health Organization, 2016.
|
[27] |
Nicol MP, Gnanashanmugam D, Browning R , et al. A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis. Clin Infect Dis, 2015,61Suppl 3: S164-172.
doi: 10.1093/cid/civ613
URL
pmid: 26409279
|
[28] |
Deng J, Bi L, Zhou L , et al. Mycobacterium tuberculosis proteome microarray for global studies of protein function and immunogenicity. Cell Rep, 2014,9(6):2317-2329.
doi: 10.1016/j.celrep.2014.11.023
URL
|
[29] |
Liu C, Lyon CJ, Bu Y , et al. Clinical Evaluation of a Blood Assay to Diagnose Paucibacillary Tuberculosis Via Bacterial Antigens. Clin Chem, 2018,64(5):791-800.
doi: 10.1373/clinchem.2017.273698
URL
|
[30] |
World Health Organization, United Nations International Children’s Emergency Fund. Statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children. Geneva: World Health Organization, 2017.
|
[31] |
World Health Organization. The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance. Geneva: World Health Organization, 2016.
|